Evidence mapPaperPMID 41301409Full record

ArticleBiomolecules2025

Exploring the Association of

Nicolas Fragoso-Bargas, Litzy Naomi Toloza-Couoh, Irma Quintal-Ortiz, Guillermo Valencia-Pacheco, Nina Valadez-Gonzalez

Abstract read
In one paragraph

Article in Biomolecules, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nicolas Fragoso-BargasMohn Center for Diabetes Precision Medicine, Department of Clinical Science, University of Bergen, 5009 Bergen, Norway.ORCID 0000-0002-6412-7671
Litzy Naomi Toloza-CouohHematology Laboratory, Regional Research Center "Dr. Hideyo Noguchi", Autonomous University of Yucatán, Yucatán 97225, Mexico.ORCID 0009-0009-8871-2136
Irma Quintal-OrtizHematology Laboratory, Regional Research Center "Dr. Hideyo Noguchi", Autonomous University of Yucatán, Yucatán 97225, Mexico.
Guillermo Valencia-PachecoHematology Laboratory, Regional Research Center "Dr. Hideyo Noguchi", Autonomous University of Yucatán, Yucatán 97225, Mexico.ORCID 0000-0002-6633-130X
Nina Valadez-GonzalezHematology Laboratory, Regional Research Center "Dr. Hideyo Noguchi", Autonomous University of Yucatán, Yucatán 97225, Mexico.ORCID 0000-0003-4584-7240

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type 2 diabetes (T2D) is a multifactorial disease characterized by chronic hyperglycemia. The

Indexed as

Alpha-Ketoglutarate-Dependent Dioxygenase FTOBlood GlucoseDiabetes Mellitus, Type 2Glycated HemoglobinAdultAgedAllelesFastingFemaleGenetic Predisposition to DiseaseHumansMaleMexicoMiddle AgedPolymorphism, Single NucleotideAlpha-Ketoglutarate-Dependent Dioxygenase FTOBlood GlucoseFTO protein, humanGlycated Hemoglobinhemoglobin A1c protein, humanbiomarkersFTOgenetic variantglucoseHbA1cMayapolymorphismrs9939609SNPSNVType 2 diabetes

Identifiers

PMID41301409
PMCPMC12650074

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.